RUNX1 and acute myeloid leukemia: To investigate RUNX1 depletion-mediated cellular responses, we have constructed tetracycline-inducible shRNAs targeting RUNX1 (sh_RUNX1 #1 and #2) and lentivirally-transduced them into AML-derived MV4-11 cells.